After the synthesis and the analytical characterization of the conjugates, the impedimetric measurement revealed that the GnRH-I-[4Ser] and GnRH-II-[4Ser] conjugates had comparable tumor growth inhibitory effects in HT-29 cells, which confirms our previous findings [12]. This evidence concerns the gene GNRH1 and neoplasm.